software as a medical device
Teva UK and Closed Loop Medicine partner to advance development of personalised medicines
The collaboration will utilise Closed Loop Medicine’s software as a medical device technology platform
Applying Vibrotactile Stimulation to Improve Parkinson’s
Lucy Jung, CEO & Founder of Charco Neurotech, shares how meeting members of the Parkinson's community catalyzed the founding of Charco and how #innovative medical devices and software can improve...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators.
Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today.
Rare genetic diseases – what’s in store for 2021?
Why personalised medicine based on our own genomes is the future of healthcare
Immuno-oncology, personalised medicine continues to drive pharma sector
New GlobalData survey identifies key trends impacting the industry
Personalised medicine can improve treatment, but access still an issue
Barriers to access could harm uptake of potentially transformative therapies
The changing face of pharma in the precision era
Blue Latitude Health speaks to Nancy Brandt, a Senior Leader in Global Medical Information at a top 20 biopharma organisation. Here, she reveals what pharmaceutical companies need to do to...
Battling breast cancer with precision medicine (Part 1)
Laura Holmes Haddad is a breast cancer survivor. She made the incredibly brave decision to participate in a PARP inhibitor precision medicine trial. Here, the author and precision medicine advocate...
Hancock says UK genome service is now ‘rolling out’
Health secretary also announces a £240m social care boost
Call for genetic tests to bring personalised medicine to children with cancer
Action needed as childhood cancer survival has plateaued